These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 88850)

  • 1. [Use of electromyography of the bladder sphincter for the differentiation of prostate adenoma and prostate carcinoma].
    Steinhauser I
    Z Urol Nephrol; 1979 Mar; 72(3):171-3. PubMed ID: 88850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of hydroxyproline excretion in the urine (UHP) in prostate carcinoma].
    Pust R; Rost A; Weidner W; Rothauge CF
    Z Urol Nephrol; 1979 Mar; 72(3):159-70. PubMed ID: 463372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacologic study of nicergoline in the pathology of the cervico-prostatic sphincter].
    Ghaddar Y; Caissel J; Léandri P; Rossignol G
    Ann Urol (Paris); 1987; 21(2):107-14. PubMed ID: 2441642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance (MR) imaging of prostatic tumours, a comparison with X-ray CT and transrectal sonography (TRS).
    Bockisch A; Jäger N; Biersack HJ; Vahlensieck W; Hünermann B; Schmitz HG; Knopp R; Christ F; Winkler C
    Eur J Radiol; 1988 Feb; 8(1):54-9. PubMed ID: 2451610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of suprapubic prostate and urinary bladder sonography].
    Hubrich W; Liesebach M; Fleck H; Raatzsch H
    Z Urol Nephrol; 1986 Jun; 79(6):347-55. PubMed ID: 2428185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical relevance of incidental prostate carcinoma. A retrospective study].
    Schürholz T; Schulze H; Finke W; Lange S; Senge T
    Urologe A; 1996 Jul; 35(4):315-20. PubMed ID: 8928361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transabdominal prostatic sonography and bladder neck-colliculus distance measurement for preoperative determination of prostatic weight: 2 methods in comparison].
    Wiedemann A; Holtmann G
    Z Urol Nephrol; 1990 Mar; 83(3):101-3. PubMed ID: 1694054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
    Hübler J; Jávor A
    Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystometry and simultaneous electomyography from the striated uretheral and anal sphincters and from levator ani.
    Sundin T; Petersén I
    Invest Urol; 1975 Jul; 13(1):40-6. PubMed ID: 1140918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
    Bauer HW; Schmiedt E
    Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].
    Gualdi GF; Polettini E; Casciani E
    Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of MR imaging and urodynamic findings in benign prostatic hyperplasia.
    Alam AM; Sugimura K; Okizuka H; Ishida J; Igawa M
    Radiat Med; 2000; 18(2):123-8. PubMed ID: 10888045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic squamous cell cancer and its differential diagnostic contrast with squamous cell metaplasia].
    Samsonov VA
    Arkh Patol; 1984; 46(8):23-9. PubMed ID: 6208883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated prostate-specific antigen: a case report and analysis.
    Hicks RJ
    J Fam Pract; 1993 Sep; 37(3):284-8. PubMed ID: 7691981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate carcinoma: atrophy or not atrophy that is the question.
    Mikuz G; Algaba F; Beltran AL; Montironi R
    Eur Urol; 2007 Nov; 52(5):1293-6. PubMed ID: 17761384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.